anti-inflammatories Archives
CRISPR screen identifies new anti-inflammatory drug target
Nov. 11, 2021—A novel CRISPR screen developed by Vanderbilt researchers identified a promising new target for anti-inflammatory therapeutics.
Cell death pathway implicated in bone marrow failure
Jan. 31, 2019—Vanderbilt investigators have linked a specific form of programmed cell death to myelodysplastic syndrome, a type of bone marrow failure.
Pain relievers a risk for C. diff?
Jan. 17, 2019—A link between anti-inflammatory drugs such as ibuprofen and C. diff infection suggests caution against overusing such drugs in patients at high risk for infection.
A spicy finding
Jan. 16, 2018—Vanderbilt researchers have discovered that curcumin — the active ingredient in the spice turmeric — needs to be metabolically activated to exert anti-inflammatory effects.
VU, Celgene announce research partnership
Jul. 10, 2014—Vanderbilt University has formed a scientific partnership with Celgene Corporation to investigate new uses for the company’s anti-inflammatory drugs that are already on the market.
Inflammation relief: what’s the delay?
Jun. 28, 2011—New research offers hope for patients needing the anti-inflammatory benefits of glucocorticoids without the adverse side effects associated with them.
